| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:MYBL1-MMP16 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: MYBL1-MMP16 | FusionPDB ID: 56172 | FusionGDB2.0 ID: 56172 | Hgene | Tgene | Gene symbol | MYBL1 | MMP16 | Gene ID | 4603 | 4325 |
| Gene name | MYB proto-oncogene like 1 | matrix metallopeptidase 16 | |
| Synonyms | A-MYB|AMYB | C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP | |
| Cytomap | 8q13.1 | 8q21.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | myb-related protein Amyb-like protein 1v-myb avian myeloblastosis viral oncogene homolog-like 1 | matrix metalloproteinase-16MMP-16MT-MMP 3MT3MMPMTMMP3Putative transmembrane protein C8orf57matrix metallopeptidase 16 (membrane-inserted)membrane-type matrix metalloproteinase 3membrane-type-3 matrix metalloproteinase | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P10243 | P51512 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000517885, ENST00000522677, ENST00000524176, ENST00000522419, | ENST00000544227, ENST00000286614, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 5 X 8 X 4=160 | 4 X 3 X 3=36 |
| # samples | 4 | 4 | |
| ** MAII score | log2(4/160*10)=-2 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: MYBL1 [Title/Abstract] AND MMP16 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | MYBL1(67484717)-MMP16(89086971), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | MYBL1-MMP16 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MYBL1-MMP16 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MYBL1-MMP16 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. MYBL1-MMP16 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | MYBL1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 7987850 |
| Tgene | MMP16 | GO:0006508 | proteolysis | 24970228 |
| Tgene | MMP16 | GO:0016485 | protein processing | 27229514 |
| Fusion gene breakpoints across MYBL1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across MMP16 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-AR-A0TY-01A | MYBL1 | chr8 | 67484717 | - | MMP16 | chr8 | 89086971 | - |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000522677 | MYBL1 | chr8 | 67484717 | - | ENST00000286614 | MMP16 | chr8 | 89086971 | - | 12332 | 2139 | 411 | 2879 | 822 |
| ENST00000517885 | MYBL1 | chr8 | 67484717 | - | ENST00000286614 | MMP16 | chr8 | 89086971 | - | 11351 | 1158 | 456 | 1898 | 480 |
| ENST00000524176 | MYBL1 | chr8 | 67484717 | - | ENST00000286614 | MMP16 | chr8 | 89086971 | - | 11990 | 1797 | 69 | 2537 | 822 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000522677 | ENST00000286614 | MYBL1 | chr8 | 67484717 | - | MMP16 | chr8 | 89086971 | - | 0.000151479 | 0.9998485 |
| ENST00000517885 | ENST00000286614 | MYBL1 | chr8 | 67484717 | - | MMP16 | chr8 | 89086971 | - | 0.000112755 | 0.9998872 |
| ENST00000524176 | ENST00000286614 | MYBL1 | chr8 | 67484717 | - | MMP16 | chr8 | 89086971 | - | 0.000145633 | 0.9998543 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >56172_56172_1_MYBL1-MMP16_MYBL1_chr8_67484717_ENST00000517885_MMP16_chr8_89086971_ENST00000286614_length(amino acids)=480AA_BP=234 MAKRSRSEDEDDDLQYADHDYEVPQQKGLKKLWNRVKWTRDEDDKLKKLVEQHGTDDWTLIASHLQNRSDFQCQHRWQKVLNPELIKGPW TKEEDQRVIELVQKYGKKRKMRVGHSPGSELRDGSLNDGGNMALKHTPLKTLPFSPSQFFNTCPGNEQLNIENPSFTSTPICGQKALITT PLHKETTPKDQKENVGFRTPTIRRSILGTTPRTPTPFKNALAAQEKKYGPLKIVDQWFWRVRNNRVMDGYPMQITYFWRGLPPSIDAVYE NSDGNFVFFKGNKYWVFKDTTLQPGYPHDLITLGSGIPPHGIDSAIWWEDVGKTYFFKGDRYWRYSEEMKTMDPGYPKPITVWKGIPESP QGAFVHKENGFTYFYKGKEYWKFNNQILKVEPGYPRSILKDFMGCDGPTDRVKEGHSPPDDVDIVIKLDNTASTVKAIAIVIPCILALCL -------------------------------------------------------------- >56172_56172_2_MYBL1-MMP16_MYBL1_chr8_67484717_ENST00000522677_MMP16_chr8_89086971_ENST00000286614_length(amino acids)=822AA_BP=576 MAKRSRSEDEDDDLQYADHDYEVPQQKGLKKLWNRVKWTRDEDDKLKKLVEQHGTDDWTLIASHLQNRSDFQCQHRWQKVLNPELIKGPW TKEEDQRVIELVQKYGPKRWSLIAKHLKGRIGKQCRERWHNHLNPEVKKSSWTEEEDRIIYEAHKRLGNRWAEIAKLLPGRTDNSIKNHW NSTMRRKVEQEGYLQDGIKSERSSSKLQHKPCAAMDHMQTQNQFYIPVQIPGYQYVSPEGNCIEHVQPTSAFIQQPFIDEDPDKEKKIKE LEMLLMSAENEVRRKRIPSQPGSFSSWSGSFLMDDNMSNTLNSLDEHTSEFYSMDENQPVSAQQNSPTKFLAVEANAVLSSLQTIPEFAE TLELIESDPVAWSDVTSFDISDAAASPIKSTPVKLMRIQHNEGAMECQFNVSLVLEGKKNTCNGGNSEAVPLTSPNIAKFSTPPAILRKK RKMRVGHSPGSELRDGSLNDGGNMALKHTPLKTLPFSPSQFFNTCPGNEQLNIENPSFTSTPICGQKALITTPLHKETTPKDQKENVGFR TPTIRRSILGTTPRTPTPFKNALAAQEKKYGPLKIVDQWFWRVRNNRVMDGYPMQITYFWRGLPPSIDAVYENSDGNFVFFKGNKYWVFK DTTLQPGYPHDLITLGSGIPPHGIDSAIWWEDVGKTYFFKGDRYWRYSEEMKTMDPGYPKPITVWKGIPESPQGAFVHKENGFTYFYKGK EYWKFNNQILKVEPGYPRSILKDFMGCDGPTDRVKEGHSPPDDVDIVIKLDNTASTVKAIAIVIPCILALCLLVLVYTVFQFKRKGTPRH -------------------------------------------------------------- >56172_56172_3_MYBL1-MMP16_MYBL1_chr8_67484717_ENST00000524176_MMP16_chr8_89086971_ENST00000286614_length(amino acids)=822AA_BP=576 MAKRSRSEDEDDDLQYADHDYEVPQQKGLKKLWNRVKWTRDEDDKLKKLVEQHGTDDWTLIASHLQNRSDFQCQHRWQKVLNPELIKGPW TKEEDQRVIELVQKYGPKRWSLIAKHLKGRIGKQCRERWHNHLNPEVKKSSWTEEEDRIIYEAHKRLGNRWAEIAKLLPGRTDNSIKNHW NSTMRRKVEQEGYLQDGIKSERSSSKLQHKPCAAMDHMQTQNQFYIPVQIPGYQYVSPEGNCIEHVQPTSAFIQQPFIDEDPDKEKKIKE LEMLLMSAENEVRRKRIPSQPGSFSSWSGSFLMDDNMSNTLNSLDEHTSEFYSMDENQPVSAQQNSPTKFLAVEANAVLSSLQTIPEFAE TLELIESDPVAWSDVTSFDISDAAASPIKSTPVKLMRIQHNEGAMECQFNVSLVLEGKKNTCNGGNSEAVPLTSPNIAKFSTPPAILRKK RKMRVGHSPGSELRDGSLNDGGNMALKHTPLKTLPFSPSQFFNTCPGNEQLNIENPSFTSTPICGQKALITTPLHKETTPKDQKENVGFR TPTIRRSILGTTPRTPTPFKNALAAQEKKYGPLKIVDQWFWRVRNNRVMDGYPMQITYFWRGLPPSIDAVYENSDGNFVFFKGNKYWVFK DTTLQPGYPHDLITLGSGIPPHGIDSAIWWEDVGKTYFFKGDRYWRYSEEMKTMDPGYPKPITVWKGIPESPQGAFVHKENGFTYFYKGK EYWKFNNQILKVEPGYPRSILKDFMGCDGPTDRVKEGHSPPDDVDIVIKLDNTASTVKAIAIVIPCILALCLLVLVYTVFQFKRKGTPRH -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:67484717/chr8:89086971) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MYBL1 | MMP16 |
| FUNCTION: Transcription factor that specifically recognizes the sequence 5'-YAAC[GT]G-3' (PubMed:8058310, PubMed:7987850). Acts as a master regulator of male meiosis by promoting expression of piRNAs: activates expression of both piRNA precursor RNAs and expression of protein-coding genes involved in piRNA metabolism (By similarity). The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons, which is essential for the germline integrity (By similarity). Transcriptional activator of SOX30 (By similarity). {ECO:0000250|UniProtKB:P51960, ECO:0000269|PubMed:7987850, ECO:0000269|PubMed:8058310}. | FUNCTION: Endopeptidase that degrades various components of the extracellular matrix, such as collagen type III and fibronectin. Activates progelatinase A. Involved in the matrix remodeling of blood vessels. Isoform short cleaves fibronectin and also collagen type III, but at lower rate. It has no effect on type I, II, IV and V collagen. However, upon interaction with CSPG4, it may be involved in degradation and invasion of type I collagen by melanoma cells. {ECO:0000269|PubMed:11278606}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000522677 | - | 12 | 16 | 110_133 | 576.0 | 753.0 | DNA binding | H-T-H motif |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000522677 | - | 12 | 16 | 161_184 | 576.0 | 753.0 | DNA binding | H-T-H motif |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000522677 | - | 12 | 16 | 58_81 | 576.0 | 753.0 | DNA binding | H-T-H motif |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000524176 | - | 12 | 15 | 110_133 | 576.0 | 693.0 | DNA binding | H-T-H motif |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000524176 | - | 12 | 15 | 161_184 | 576.0 | 693.0 | DNA binding | H-T-H motif |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000524176 | - | 12 | 15 | 58_81 | 576.0 | 693.0 | DNA binding | H-T-H motif |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000522677 | - | 12 | 16 | 138_188 | 576.0 | 753.0 | Domain | HTH myb-type 3 |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000522677 | - | 12 | 16 | 30_81 | 576.0 | 753.0 | Domain | HTH myb-type 1 |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000522677 | - | 12 | 16 | 82_137 | 576.0 | 753.0 | Domain | HTH myb-type 2 |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000524176 | - | 12 | 15 | 138_188 | 576.0 | 693.0 | Domain | HTH myb-type 3 |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000524176 | - | 12 | 15 | 30_81 | 576.0 | 693.0 | Domain | HTH myb-type 1 |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000524176 | - | 12 | 15 | 82_137 | 576.0 | 693.0 | Domain | HTH myb-type 2 |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000522677 | - | 12 | 16 | 230_295 | 576.0 | 753.0 | Region | Transcriptional activation domain |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000522677 | - | 12 | 16 | 298_553 | 576.0 | 753.0 | Region | Negative regulatory domain |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000524176 | - | 12 | 15 | 230_295 | 576.0 | 693.0 | Region | Transcriptional activation domain |
| Hgene | MYBL1 | chr8:67484717 | chr8:89086971 | ENST00000524176 | - | 12 | 15 | 298_553 | 576.0 | 693.0 | Region | Negative regulatory domain |
| Tgene | MMP16 | chr8:67484717 | chr8:89086971 | ENST00000286614 | 5 | 10 | 389_434 | 361.0 | 608.0 | Repeat | Note=Hemopexin 2 | |
| Tgene | MMP16 | chr8:67484717 | chr8:89086971 | ENST00000286614 | 5 | 10 | 436_484 | 361.0 | 608.0 | Repeat | Note=Hemopexin 3 | |
| Tgene | MMP16 | chr8:67484717 | chr8:89086971 | ENST00000286614 | 5 | 10 | 485_532 | 361.0 | 608.0 | Repeat | Note=Hemopexin 4 | |
| Tgene | MMP16 | chr8:67484717 | chr8:89086971 | ENST00000286614 | 5 | 10 | 586_607 | 361.0 | 608.0 | Topological domain | Cytoplasmic | |
| Tgene | MMP16 | chr8:67484717 | chr8:89086971 | ENST00000286614 | 5 | 10 | 565_585 | 361.0 | 608.0 | Transmembrane | Helical |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | MMP16 | chr8:67484717 | chr8:89086971 | ENST00000286614 | 5 | 10 | 99_106 | 361.0 | 608.0 | Motif | Cysteine switch | |
| Tgene | MMP16 | chr8:67484717 | chr8:89086971 | ENST00000286614 | 5 | 10 | 340_388 | 361.0 | 608.0 | Repeat | Note=Hemopexin 1 | |
| Tgene | MMP16 | chr8:67484717 | chr8:89086971 | ENST00000286614 | 5 | 10 | 120_564 | 361.0 | 608.0 | Topological domain | Extracellular |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| MYBL1 | |
| MMP16 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to MYBL1-MMP16 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to MYBL1-MMP16 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies